ALLR — Allarity Therapeutics, Inc.
Fresh Supply424B filed ~105d ago🌀 Serial Splitter⚰️ Delisting Watch📄 Fresh Paper1-for-645,316 cumulative
XBRL EDGAR
424B filed ~105d ago
Case Notes
Allarity Therapeutics, Inc. has 5 reverse splits on record — cumulative 1-for-645,316. Its share count grew 5.5% over the last twelve months per XBRL EDGAR data.
Most recent stress filing: 10-Q on 2026-05-18, flagging Going concern, Capital need. 3 supply registrations (S-1/424B) landed in the last 12 months.
Registered shares exist to be sold — that is what the S-1 and 424B instruments document. In our research across this filing posture, freshly registered supply is the loaded state of the cycle: the paperwork has created the legal right to place shares into the market. That is not a prediction — it is what the filings say is possible.
Share Count Over Time
XBRL cover-page share counts from SEC EDGAR filings. Amber dashed lines mark reverse-split dates. 5 reverse splits on record.
Reverse Split Log
Each event consolidates shares — fewer shares, same market cap. Source: EDGAR corporate actions.
Cumulative effective ratio: 1-for-645,316— a share held at inception is now worth 1/645,316 of its original fraction.
Filing Stress Record
Stress-language flags extracted from SEC EDGAR 10-K/10-Q filings. Score 1–10 reflects language intensity.
| Date | Form | Score | Flags |
|---|---|---|---|
| 2024-08-06 | 10-Q | 4/10 | Going concernCapital needATM/ELOCListing compliance |
| 2024-11-15 | 10-Q | 0/10 | |
| 2025-04-01 | 10-K | 3/10 | Capital needATM/ELOCListing compliance |
| 2025-05-12 | 10-Q | 3/10 | Going concernCapital needSplit intent |
| 2025-08-18 | 10-Q | 0/10 | |
| 2025-11-14 | 10-Q | 0/10 | |
| 2026-03-31 | 10-K | 2/10 | Capital needListing compliance |
| 2026-05-18 | 10-Q | 2/10 | Going concernCapital need |
Source: public EDGAR records.
424B Supply Pulse
Prospectus supplements (424B5) filed registering shares for resale — each bar is one month with a filing. Bars above average signal active distribution windows. Source: SEC EDGAR.